Relative costs of gynecologic endoscopy vs traditional surgery for treatment of abnormal uterine bleeding.

Background: The traditional treatment for abnormal uterine bleeding when medical therapy fails has been abdominal or vaginal hysterectomy. More recently, operative gynecologic endoscopy (laparoscopy and hysteroscopy) has partially replaced this traditional approach. The cost and healthcare utilization of endoscopy compared with traditional surgical methods are poorly understood.

Cost and quality-of-life issues associated with different surgical therapies for the treatment of abnormal uterine bleeding.

Abnormal uterine bleeding is a common problem among women of reproductive age and can be treated medically or surgically. When medical therapy fails to cure menorrhagia, many women undergo hysterectomy. Over the past 15 years, operative laparoscopy and hysteroscopy increasingly have replaced traditional surgery (i.

Cost of different types of surgical therapy for abnormal uterine bleeding. A review.

Treatment of abnormal uterine bleeding by abdominal or vaginal hysterectomy has been partially replaced by operative endoscopy. Operative endoscopy (laparoscopy and hysteroscopy), appropriately employed, might offer numerous advantages, such as decreased hospital stay, complications and discomfort. The cost and health care utilization of operative laparoscopy and hysteroscopy as compared to traditional surgical methods are less understood.

Long-term economic evaluation of resectoscopic endometrial ablation versus hysterectomy for the treatment of menorrhagia.

Study Objective: To assess long-term costs of resectoscopic endometrial ablation versus hysterectomy in women with menorrhagia.

Design: Controlled cohort study (Canadian Task Force classification II-2).

Setting: Multispeciality group practice.

Cost of assisted reproductive technologies for a health maintenance organization.

Objective: To calculate the cost of assisted reproductive technologies (ART) for a health maintenance organization (HMO), assess factors that contribute to the cost per delivery and to analyze how utilization rates can be controlled by the use of clinical criteria.

Study Design: Pregnancy outcome and a cost analysis of all ART cycles at an HMO in a state with mandated coverage for these procedures was performed. All patients (n = 148) undergoing ART cycles insured by the HMO performed at one in vitro fertilization (IVF) center during 1990-1995 were studied.